155 related articles for article (PubMed ID: 35347751)
21. Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis.
Raffone A; Travaglino A; Saccone G; Campanino MR; Mollo A; De Placido G; Insabato L; Zullo F
Acta Obstet Gynecol Scand; 2019 Mar; 98(3):275-286. PubMed ID: 30511743
[TBL] [Abstract][Full Text] [Related]
22. Mucinous Proliferations of the Uterine Corpus: Comprehensive Appraisal of an Evolving Spectrum of Neoplasms.
Fadare O
Adv Anat Pathol; 2022 Sep; 29(5):275-296. PubMed ID: 35499137
[TBL] [Abstract][Full Text] [Related]
23. [Immunohistochemical expression of PTEN antigen: a new tool for diagnosis of early endometrial neoplasia].
Taranger-Charpin C; Carpentier S; Dales JP; Garcia S; Djemli A; Andrac L; Lavaut MN; Sferlazzo K; Boubli L
Bull Acad Natl Med; 2004; 188(3):415-27; discussion 427-9. PubMed ID: 15584653
[TBL] [Abstract][Full Text] [Related]
24. Determining the inter- and intraobserver reproducibility of the diagnosis of endometrial hyperplasia subgroups and well-differentiated endometrioid carcinoma in endometrial curettage specimens.
Izadi-Mood N; Khaniki M; Irvanloo G; Ahmadi SA; Hayeri H; Meysamie A
Arch Iran Med; 2009 Jul; 12(4):377-82. PubMed ID: 19566355
[TBL] [Abstract][Full Text] [Related]
25. The Evolving Spectrum of Endometrial Glandular Proliferations With Corded and Hyalinized Features.
Pors J; Weiel JJ; Ryan E; Longacre TA
Am J Surg Pathol; 2023 Sep; 47(9):1067-1076. PubMed ID: 37493099
[TBL] [Abstract][Full Text] [Related]
26. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63.
O'Connell JT; Mutter GL; Cviko A; Nucci M; Quade BJ; Kozakewich HP; Neffen E; Sun D; Yang A; McKeon FD; Crum CP
Gynecol Oncol; 2001 Jan; 80(1):30-6. PubMed ID: 11136566
[TBL] [Abstract][Full Text] [Related]
27. Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears.
Selvaggi SM; Haefner HK
Diagn Cytopathol; 1997 Feb; 16(2):168-73. PubMed ID: 9067112
[TBL] [Abstract][Full Text] [Related]
28. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma.
Kendall BS; Ronnett BM; Isacson C; Cho KR; Hedrick L; Diener-West M; Kurman RJ
Am J Surg Pathol; 1998 Aug; 22(8):1012-9. PubMed ID: 9706982
[TBL] [Abstract][Full Text] [Related]
29. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
30. Utility of PTEN expression of endometrial "surface epithelial changes" and underlying atypical endometrial hyperplasia.
Quddus MR; Ologun BA; Sung CJ; Steinhoff MM; Lawrence WD
Int J Gynecol Pathol; 2009 Sep; 28(5):471-6. PubMed ID: 19696618
[TBL] [Abstract][Full Text] [Related]
31. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
Lax S
Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
[TBL] [Abstract][Full Text] [Related]
32. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
Taylor J; McCluggage WG
Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
[TBL] [Abstract][Full Text] [Related]
33. Mucinous metaplasia of the endometrium: current concepts.
Turashvili G; Childs T
Gynecol Oncol; 2015 Feb; 136(2):389-93. PubMed ID: 25485781
[TBL] [Abstract][Full Text] [Related]
34. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
35. Localized Endometrial Proliferations of Pregnancy are Clonal Glandular Outgrowths Characterized by PTEN Loss and PIK3CA Pathogenic Variants.
Wepy C; Chapel DB; Mutter GL; Quade BJ; Nucci MR; Parra-Herran C
Mod Pathol; 2023 Aug; 36(8):100213. PubMed ID: 37172903
[TBL] [Abstract][Full Text] [Related]
36. Affinity of four lectins for endocervical and endometrial non-neoplastic and neoplastic glandular epithelium.
Toda T; Sadi AM; Egawa H; Atari E; Qureshi B; Nagai Y
Histopathology; 1998 Mar; 32(3):257-63. PubMed ID: 9568512
[TBL] [Abstract][Full Text] [Related]
37. A case of microglandular adenocarcinoma of the endometrium.
Karateke A; Haliloglu B; Atay V; Gurbuz A; Kir G
Gynecol Oncol; 2005 Dec; 99(3):778-81. PubMed ID: 16229880
[TBL] [Abstract][Full Text] [Related]
38. [Precursor lesions of endometrial carcinoma].
Lax SF
Pathologe; 2019 Feb; 40(1):13-20. PubMed ID: 30707274
[TBL] [Abstract][Full Text] [Related]
39. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
[TBL] [Abstract][Full Text] [Related]
40. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
Tambouret R; Clement PB; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]